Skip to main content
Year archive

Telix Pharmaceuticals Ltd — 2025 filings

All 147 regulatory filings released by Telix Pharmaceuticals Ltd (TLX) in 2025, sourced directly from the official regulator.

147 Filings
2025 Period
2025 filings (147)
Filing Released Lang
Application for quotation of securities - TLX 8 pages 25.7KB
Share Issue/Capital Change
2025-12-23 English
Notification regarding unquoted securities - TLX 7 pages 22.0KB
Share Issue/Capital Change
2025-12-23 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-12-22 English
Precision Medicine Portfolio Update 4 pages 265.7KB
Capital/Financing Update
2025-12-21 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-12-17 English
ProstACT Global Study Status 3 pages 230.5KB
Regulatory Filings
2025-12-16 English
Securities Dealing Policy - Updated 12 pages 463.3KB
Regulatory Filings
2025-12-14 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-12-08 English
1st Patient Dosed in ProstACT Global Randomized Tx Expansion 3 pages 220.6KB
Regulatory Filings
2025-12-07 English
Becoming a substantial holder 62 pages 3.9MB
Major Shareholding Notification
2025-11-16 English
Application for quotation of securities - TLX 8 pages 25.6KB
Share Issue/Capital Change
2025-11-06 English
Appendix 3Y Change in Director Interests - C Behrenbruch 3 pages 342.0KB
Director's Dealing
2025-11-06 English
Application for quotation of securities - TLX 6 pages 20.0KB
Share Issue/Capital Change
2025-10-28 English
Cleansing Notice 1 page 160.6KB
Share Issue/Capital Change
2025-10-28 English
Pending Release of Shares from Voluntary Escrow 2 pages 197.0KB
Regulatory Filings
2025-10-28 English
Pending Release of Shares from Voluntary Escrow 2 pages 198.0KB
Share Issue/Capital Change
2025-10-23 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-10-14 English
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded 5 pages 153.7KB
Interim / Quarterly Report Q3 2025
2025-10-13 English
Application for quotation of securities - TLX 8 pages 25.6KB
Share Issue/Capital Change
2025-10-09 English
Notification regarding unquoted securities - TLX 5 pages 17.5KB
Share Issue/Capital Change
2025-10-09 English
Notification of cessation of securities - TLX 6 pages 18.6KB
Regulatory Filings
2025-10-09 English
Change in substantial holding 120 pages 812.9KB
Major Shareholding Notification
2025-10-07 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-09-23 English
CMS Grants Transitional Pass-Through Status for Gozellix 3 pages 215.7KB
Regulatory Filings
2025-09-22 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-09-09 English
Telix and FDA Agree Resubmission Pathway for Pixclara NDA 3 pages 214.4KB
Regulatory Filings
2025-09-08 English
Pending Release of Shares from Voluntary Escrow 2 pages 208.1KB
Capital/Financing Update
2025-09-04 English
Application for quotation of securities - TLX 8 pages 25.1KB
Share Issue/Capital Change
2025-09-04 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-08-28 English
Telix Provides Regulatory Update on TLX250-CDx 3 pages 216.3KB
Regulatory Filings
2025-08-27 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-08-21 English
Telix H1 2025 Appendix 4D and Interim Report 53 pages 6.4MB
Interim / Quarterly Report H1 2025
2025-08-20 English
Telix H1 2025 Results Announcement 4 pages 224.8KB
Interim / Quarterly Report H1 2025
2025-08-20 English
Telix H1 2025 Results Presentation 38 pages 2.8MB
Interim / Quarterly Report H1 2025
2025-08-20 English
Historical Financials in USD and H12025 OPEX (Unaudited) 10 pages 1.8MB
Interim / Quarterly Report H1 2025
2025-08-04 English
Telix H1 2025 Results - Investor Webcast Notification 2 pages 199.5KB
Report Publication Announcement
2025-07-29 English
Pending Release of Shares from Voluntary Escrow 2 pages 207.0KB
Capital/Financing Update
2025-07-22 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-07-22 English
Telix Reports US$204M Q2 Revenue, Up 63% YOY 6 pages 316.7KB
Interim / Quarterly Report Q2 2025
2025-07-21 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-07-09 English
Notification of cessation of securities - TLX 5 pages 16.7KB
Transaction in Own Shares
2025-07-08 English
Application for quotation of securities - TLX 7 pages 22.0KB
Capital/Financing Update
2025-07-08 English
Gozellix Receives Permanent HCPCS Code 3 pages 208.7KB
Regulatory Filings
2025-07-08 English
Application for quotation of securities - TLX 8 pages 25.6KB
Share Issue/Capital Change
2025-06-19 English
Notification regarding unquoted securities - TLX 7 pages 23.8KB
Share Issue/Capital Change
2025-06-17 English
App 3Y - Change in Director Interests - C Behrenbruch 4 pages 350.9KB
Director's Dealing
2025-06-17 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-06-11 English
Telix Investor Day Presentation 127 pages 8.9MB
Investor Presentation
2025-06-10 English
Notification regarding unquoted securities - TLX 7 pages 24.2KB
Share Issue/Capital Change
2025-06-04 English
Notification regarding unquoted securities - TLX 8 pages 29.9KB
Share Issue/Capital Change
2025-06-04 English
Application for quotation of securities - TLX 8 pages 25.5KB
Share Issue/Capital Change
2025-06-04 English
Notification regarding unquoted securities - TLX 5 pages 17.6KB
Share Issue/Capital Change
2025-06-04 English
App 3Z Final Director Interests - K McCann 2 pages 196.7KB
Director's Dealing
2025-05-21 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
AGM Information
2025-05-21 English
Telix Annual General Meeting Chairman and CEO Addresses 12 pages 265.6KB
AGM Information
2025-05-20 English
Telix Annual General Meeting Presentation 15 pages 1.6MB
AGM Information
2025-05-20 English
Telix Results of Annual General Meeting 5 pages 246.1KB
Declaration of Voting Results & Voting Rights Announcements
2025-05-20 English
Pending Release of Shares from Voluntary Escrow 2 pages 146.0KB
Capital/Financing Update
2025-05-18 English
Notification of cessation of securities - TLX 4 pages 15.0KB
Share Issue/Capital Change
2025-05-15 English
Notification regarding unquoted securities - TLX 6 pages 21.4KB
Share Issue/Capital Change
2025-05-15 English
Application for quotation of securities - TLX 7 pages 22.5KB
Share Issue/Capital Change
2025-05-15 English
Notification regarding unquoted securities - TLX 6 pages 19.2KB
Share Issue/Capital Change
2025-05-08 English
Application for quotation of securities - TLX 6 pages 18.7KB
Share Issue/Capital Change
2025-05-05 English
Cleansing Notice 1 page 119.8KB
Share Issue/Capital Change
2025-05-05 English
App 3Z Final Director Interests - A Whitaker 2 pages 195.8KB
Director's Dealing
2025-04-30 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Board/Management Information
2025-04-29 English
Anne Whitaker Board Resignation 2 pages 134.0KB
Board/Management Information
2025-04-28 English
Telix Provides Regulatory Update on TLX101-CDx 3 pages 153.2KB
Regulatory Filings
2025-04-27 English
Pending Release of Shares from Voluntary Escrow 2 pages 149.9KB
Regulatory Filings
2025-04-23 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-04-22 English
Pending Release of Shares from Voluntary Escrow 2 pages 147.1KB
Regulatory Filings
2025-04-21 English
Telix Reports US$186M Q1 Revenue, Up 62% YOY 5 pages 243.0KB
Interim / Quarterly Report Q1 2025
2025-04-21 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Report Publication Announcement
2025-04-17 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-04-17 English
Telix Notice of AGM, Proxy Form and Online Guide 45 pages 4.1MB
AGM Information
2025-04-16 English
IPAX-Linz Promising Efficacy for TLX101 Glioma Tx Candidate 3 pages 167.0KB
Capital/Financing Update
2025-04-15 English
Change of Registry Address Notification 1 page 73.6
Regulatory Filings
2025-04-13 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-04-08 English
Telix Responds to Recent U.S. Government Actions 3 pages 152.9KB
Regulatory Filings
2025-04-06 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-04-03 English
Anne Whitaker Appointed as Non-Executive Director 2 pages 137.5KB
Board/Management Information
2025-04-03 English
App 3X Initial Director Interests - A Whitaker 2 pages 252.4KB
Director's Dealing
2025-04-03 English
Pending Release of Shares from Voluntary Escrow 2 pages 147.2KB
Regulatory Filings
2025-04-02 English
Pending Release of Shares from Voluntary Escrow 2 pages 148.1KB
Regulatory Filings
2025-04-02 English
Application for quotation of securities - TLX 8 pages 25.7KB
Share Issue/Capital Change
2025-04-02 English
Notification of cessation of securities - TLX 4 pages 15.0KB
Share Issue/Capital Change
2025-04-02 English
Pending Release of Shares from Voluntary Escrow 2 pages 151.0KB
Regulatory Filings
2025-04-01 English
Change in substantial holding 70 pages 475.3KB
Major Shareholding Notification
2025-04-01 English
Pending Release of Shares from Voluntary Escrow 2 pages 146.1KB
Regulatory Filings
2025-03-24 English
Regulatory Filings 2025
Regulatory Filings
2025-03-20 English
FDA Approves New Prostate Cancer Imaging Agent Gozellix 3 pages 158.0KB
Regulatory Filings
2025-03-20 English
Application for quotation of securities - TLX 8 pages 25.4KB
Share Issue/Capital Change
2025-03-20 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-03-18 English
Illuccix Approved in Brazil - 1st PSMA-PET Approval in LATAM 4 pages 206.3KB
Capital/Financing Update
2025-03-17 English
Application for quotation of securities - TLX 6 pages 18.7KB
Share Issue/Capital Change
2025-03-16 English
Cleansing Notice 1 page 119.8KB
Regulatory Filings
2025-03-16 English
Application for quotation of securities - TLX 6 pages 19.9KB
Share Issue/Capital Change
2025-03-16 English
Cleansing Notice 1 page 118.7KB
Share Issue/Capital Change
2025-03-16 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-03-12 English
Telix Completes FAP-Targeting Theranostic Acquisition 3 pages 145.0KB
Capital/Financing Update
2025-03-11 English
App 3Y Change of Director Interests - C Behrenbruch 3 pages 303.9KB
Director's Dealing
2025-03-11 English
Notification of cessation of securities - TLX 4 pages 15.7KB
Regulatory Filings
2025-03-11 English
App 3Y Change in Director Interests - M McDonald 2 pages 282.7KB
Director's Dealing
2025-03-06 English
App 3Y Change in Director Interests - T Olson 2 pages 240.0KB
Director's Dealing
2025-03-05 English
App 3Y Change in Director Interests - HK McCann 3 pages 267.8KB
Director's Dealing
2025-03-04 English
Telix Investor Webinar -Tx Urology Showcase and Expert Forum 2 pages 151.7KB
Investor Presentation
2025-03-03 English
App 3X Initial Director Interests - M McDonald 2 pages 238.7KB
Director's Dealing
2025-03-02 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-02-26 English
Completion of Sale of Shares by Telix CEO 2 pages 143.8KB
Director's Dealing
2025-02-26 English
App 3Y Change in Director Interests - C Behrenbruch 3 pages 304.0KB
Director's Dealing
2025-02-26 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-02-26 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Board/Management Information
2025-02-25 English
Telix Announces Board Renewal 3 pages 152.7KB
Board/Management Information
2025-02-25 English
FDA accepts BLA and grants priority review for Zircaix 3 pages 156.8KB
Regulatory Filings
2025-02-25 English
Notice of Pending Sale of Shares by Telix CEO 2 pages 141.9KB
Director's Dealing
2025-02-25 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-02-24 English
Telix Announces Change in Reporting Currency to USD 2 pages 133.6KB
Regulatory Filings
2025-02-24 English
20-F
Annual Report FY 2024
2025-02-24 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-02-21 English
Appendix 4E and 2024 Annual Report 178 pages 25.0MB
Regulatory Filings
2025-02-19 English
2024 Full Year Results Announcement 4 pages 183.0KB
Annual Report FY 2024
2025-02-19 English
2024 Full Year Results Presentation 41 pages 3.4MB
Investor Presentation
2025-02-19 English
Appendix 4G and 2024 Corporate Governance Statement 32 pages 5.2MB
Regulatory Filings
2025-02-19 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-14 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-14 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-02-13 English
Illuccix Approved in the United Kingdom 3 pages 189.4KB
Regulatory Filings
2025-02-12 English
Telix 2024 Full Year Results and Investor Webcast/Call 2 pages 144.8KB
Report Publication Announcement
2025-02-10 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-01-31 English
Telix Completes Acquisition of Tx Assets, Biologics Platform 4 pages 165.8KB
Capital/Financing Update
2025-01-30 English
Application for quotation of securities - TLX 6 pages 19.0KB
Share Issue/Capital Change
2025-01-30 English
Cleansing Notice 1 page 118.7KB
Share Issue/Capital Change
2025-01-30 English
Notification regarding unquoted securities - TLX 6 pages 21.1KB
Share Issue/Capital Change
2025-01-30 English
Application for quotation of securities - TLX 6 pages 18.7KB
Share Issue/Capital Change
2025-01-30 English
Cleansing Notice 1 page 119.8KB
Share Issue/Capital Change
2025-01-30 English
Regulatory Filings 2025
Regulatory Filings
2025-01-27 English
Telix Completes Acquisition of RLS (USA) Inc 3 pages 156.1KB
M&A Activity
2025-01-27 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-01-17 English
Illuccix Receives European Approval 3 pages 162.6KB
Regulatory Filings
2025-01-16 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-01-13 English
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
Regulatory Filings
2025-01-13 English
TLX to Acquire Next-Gen Therapeutics and Biologics Platform 5 pages 238.3KB
Capital/Financing Update
2025-01-12 English
Presentation to Accompany Biologics Platform Acquisition 14 pages 1.0MB
Investor Presentation
2025-01-12 English
Proposed issue of securities - TLX 6 pages 22.3KB
Capital/Financing Update
2025-01-12 English
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue 4 pages 187.3KB
Interim / Quarterly Report Q4 2024
2025-01-12 English
Telix JP Morgan Healthcare Conference 2025 Presentation 33 pages 4.4MB
Investor Presentation
2025-01-12 English
Notification of cessation of securities - TLX 4 pages 15.5KB
Major Shareholding Notification
2025-01-08 English